66736-1-Ig

antibody from Proteintech Group

Targeting: EPHA2 ECK

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66736-1-Ig

Provider

Proteintech Group

Product name

EPHA2 antibody

Antibody type

Monoclonal

Description

KD/KO validated EPHA2 antibody (Cat. #66736-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, WB, ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1A9C3

Vial size

20ul, 150ul

References

Submitted references

Vitamin B12 as a novel USP3 deubiquitinase inhibitor suppresses cell proliferation and growth in osteosarcoma.

Shi Y, Cui J, Xiaohan L
Biochemical and biophysical research communications 2025 May 1;761:151640

---

EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma.

Zhong X, Zhu Z, Du Y, Long L, Xie Z, Zhang Y, Yao H, Lin J, Chen F
Apoptosis : an international journal on programmed cell death 2025 Feb;30(1-2):349-363

---

EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma.

Bai J, Chen Y, Sun Y, Wang X, Wang Y, Guo S, Shang Z, Shao Z
Cellular and molecular life sciences : CMLS 2024 Jun 25;81(1):278

---

Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.

Williams N, Silva F, Schmolke M
Antiviral research 2024 Aug;228:105951

---

Migration-inducing gene-7 promotes glioma cell proliferation and invasiveness via activating the MAPK signaling pathway.

Pan Z, Chen C, Huang X, Xiong Y, Kang X, Zhou J, Guo X, Zheng S, Wang C, Zheng F, Hu W
Neoplasma 2023 Aug;70(4):534-544

---

Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.

Ma X, Zhang Y, Gou D, Ma J, Du J, Wang C, Li S, Cui H
Journal of Alzheimer's disease : JAD 2022;88(2):771-785

---

EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway.

Zhao X, Liu J, Jin D, Ren C, Yang L, Zhu Y, Huang C, Ding L, Wu Z, Shen K, Zhang Z, Chen H, Wang N
Journal of oncology 2022;2022:4886907

---

EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.

Lin J, Zeng C, Zhang J, Song Z, Qi N, Liu X, Zhang Z, Li A, Chen F
Molecular therapy. Nucleic acids 2021 Sep 3;25:328-341

---

EphA2 inhibits SRA01/04 cells apoptosis by suppressing autophagy via activating PI3K/Akt/mTOR pathway.

Han J, Wang L, Lv H, Liu J, Dong Y, Shi L, Ji Q
Archives of biochemistry and biophysics 2021 Oct 30;711:109024

---

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.

Zheng D, Wu Z, Han J, Guan Q, Li Z, Zuo D, Zhang W, Wu Y
Chemico-biological interactions 2020 Sep 25;329:109202

---

Role of Nuclear Claudin-4 in Renal Cell Carcinoma.

Owari T, Sasaki T, Fujii K, Fujiwara-Tani R, Kishi S, Mori S, Mori T, Goto K, Kawahara I, Nakai Y, Miyake M, Luo Y, Tanaka N, Kondoh M, Fujimoto K, Kuniyasu H
International journal of molecular sciences 2020 Nov 6;21(21)